Market Impact likely for immunoassays and molecular testing. Lessons from previous epidemics, likely impact on both immunoassays and molecular testing. Overview of the H1N1 strain as compared to other. Immunoassay and Molecular Test Products Available on the Market Developments in the last few days of significance to the diagnostic industry. Profiles of nearly 25 specific manufacturers active in this space.

The report focuses almost exclusively on the in vitro diagnostic industry as it applies to work being done by commercial entities and products that are either in development or have been brought to market.

The market assessment provided has been assembled based on publicly available information. Company sales data and other quantitative evaluations of the markets for flu diagnostics have been developed based on publicly available information and are expressed in US dollars, no adjustments have been made for currency exchange fluctuations.

Under normal circumstances, a report of this genre would be assembled from information derived from primary and secondary sources. However, in the short time it took to research and write this report, almost all of the major scientific and industry experts were occupied with the extraordinary task of preparing for a pandemic.

reportlinker